Showing results (31-40 of 293) with videos related to
Sort By:
Pageof 30
Gene Therapy|February 12, 2010
Progress and prospects: Immunobiology of gene therapy for neurodegenerative disease: prospects and risksM M McMenamin, M J A WoodTrends in Genetics : TIG|April 19, 2011
Genetic therapies for RNA mis-splicing diseasesSuzan M Hammond, Matthew J A WoodExpert Reviews in Molecular Medicine|February 2, 2012
RNA therapy for polyglutamine neurodegenerative diseasesLauren M Watson, Matthew J A WoodJournal of Molecular Medicine (Berlin, Germany)|July 14, 2011
The miRNA pathway in neurological and skeletal muscle disease: implications for pathogenesis and therapyChristopher R Sibley, Matthew J A WoodCurrent Pharmaceutical Design|November 13, 2012
Cell penetrating peptide delivery of splice directing oligonucleotides as a treatment for Duchenne muscular dystrophyCorinne A Betts, Matthew J A WoodThe Journal of Arthroplasty|December 1, 1993
Muscle strength following total hip arthroplasty. A comparison of trochanteric osteotomy and the direct lateral approachR J Minns, R J Crawford, M L Porter, et al.International Orthopaedics|April 28, 2006
Cement pressurisation in the acetabulumF Wadia, M H A Malik, D Leonard, et al.Human Molecular Genetics|October 5, 2017
Spinal muscular atrophy: antisense oligonucleotide therapy opens the door to an integrated therapeutic landscapeMatthew J A Wood, Kevin Talbot, Melissa BowermanBiomed Research International|August 29, 2013
Development of multiexon skipping antisense oligonucleotide therapy for Duchenne muscular dystrophyYoshitsugu Aoki, Toshifumi Yokota, Matthew J A WoodJournal of Applied Physiology (Bethesda, Md. : 1985)|November 1, 1989
Control of shunt pathway perfusion in diffuse granulomatous lung diseaseL L Schulman, J A Wood, Y EnsonPageof 30